card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Blog

Q² Solutions | EA Genomics receives New York State Clinical Laboratory Certification

Q² Solutions | EA Genomics announces that it has received a Clinical Laboratory Certification from the New York State Department of Health.
Home / Blog / Q² Solutions | EA Genomics receives New York State Clinical Laboratory Certification

August 22, 2018

Morrisville, NC - August 22, 2018 – Q2 Solutions | EA Genomics is proud to announce that it has received a Clinical Laboratory Certification from the New York State Department of Health in the category of oncology testing for molecular and cellular tumor markers. With this certification, our Comprehensive Cancer Panel (QCCP) next generation sequencing-based test for FFPE/fresh/frozen tissue specimens has been approved for clinical testing on patient specimens originating from New York state. This addition to the lab’s existing CLIA certification and CAP accreditation demonstrates our proven expertise with laboratory regulations and enables the lab to process specimens received from all 50 USA states, expanding opportunities for enrollment in clinical trials.

“This accomplishment opens many new opportunities for us in relation to trials requiring prospective genomic testing globally. In addition, achieving New York State certification clearly demonstrates our focus on high quality and regulatory compliant delivery”, said Kellie Yarnell, VP, Genomic Laboratories at Q2 Solutions.

The Q2 Solutions Comprehensive Cancer Panel is a targeted sequencing assay for analysis of genomic alterations predictive of response to therapies in clinical development. This 222-gene cancer panel includes the genes associated with multiple common cancers and can be used to assess various types of alterations including base substitutions, deletions, and insertions.

About Q2 Solutions
Q2 Solutions’ industry-leading genomic and bioinformatics services provide customers with DNA and RNA sequencing and other testing as well as the ability to mine data for invaluable insights for drug discovery, precision medicine and clinical development. Q2 Solutions | EA Genomics works with clients, using a wide array of technology platforms, to ensure maximum efficiency and quality delivery for every study. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.